We are live on ! Find out more
Jarislowsky, Fraser

Jarislowsky, Fraser Portfolio holdings

AUM $18.2B Turnover 3.11%
1-Year Est. Return 22.04%
 

Jarislowsky Fraser started in 1955 as a Montreal research firm that sold its stock research to investment managers in the US and UK. Its founder, Stephen Jarislowsky, was a Harvard-educated investor and former Alcan executive. The firm won its first pension fund client by 1966, and managing money for institutions became its core business. Scotiabank bought it in 2018, and the firm kept its Montreal headquarters and its investment independence. It looks for quality, sustainable businesses to hold for long-term growth, and serves pension funds, endowments, foundations, corporations and Indigenous communities.

This Fund
S&P 500
This Quarter Est. Return
-5.22%
1 Year Est. Return
+22.04%
3 Year Est. Return
+92.62%
5 Year Est. Return
+122.31%
10 Year Est. Return
+241.46%
AUM
$15B
AUM Growth
-$1.18B
Cap. Flow
-$371M
Cap. Flow %
-2.48%
Top 10 Hldgs %
49.7%
Holding
148
New
8
Increased
33
Reduced
103
Closed
2
Avg Time Held
1.5 years
Top 10 Avg Time Held
1.4 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
ENB icon
Enbridge
ENB
+$72M
2
GIL icon
Gildan
GIL
+$70.6M
3
CVE icon
Cenovus Energy
CVE
+$60M
4
PBA icon
Pembina Pipeline
PBA
+$50.7M
5
STN icon
Stantec
STN
+$42.6M

Sector Composition

Rank Sector Weight
1 Financials 30.17%
2 Energy 24.85%
3 Industrials 13.71%
4 Technology 9.72%
5 Healthcare 8.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TD icon
1
Toronto Dominion Bank
TD
$202B
$1.16B 7.72%
27,004,690
-480,927
-2% -$20.7M
2013 Q2
7 quarters
RY icon
2
Royal Bank of Canada
RY
$280B
$1.05B 6.99%
17,368,213
-354,894
-2% -$21.8M
2013 Q2
7 quarters
BNS icon
3
Scotiabank
BNS
$113B
$898M 5.99%
18,913,154
-359,590
-2% -$17.6M
2013 Q2
7 quarters
CNI icon
4
Canadian National Railway
CNI
$76.3B
$746M 4.98%
11,135,476
-319,894
-3% -$21.8M
2013 Q2
7 quarters
ENB icon
5
Enbridge
ENB
$106B
$672M 4.48%
13,871,800
+1,497,381
+12% +$72M
2013 Q2
7 quarters
SU icon
6
Suncor Energy
SU
$80.5B
$654M 4.36%
22,368,464
-456,487
-2% -$13.6M
2013 Q2
7 quarters
CNQ icon
7
Canadian Natural Resources
CNQ
$101B
$590M 3.94%
39,831,556
-761,003
-2% -$10.9M
2013 Q2
7 quarters
MFC icon
8
Manulife Financial
MFC
$72.8B
$571M 3.81%
33,643,822
+549,285
+2% +$9.45M
2013 Q2
7 quarters
TRI icon
9
Thomson Reuters
TRI
$47.4B
$558M 3.72%
11,856,838
-296,726
-2% -$13.6M
2013 Q2
7 quarters
CVE icon
10
Cenovus Energy
CVE
$52.6B
$555M 3.7%
25,987,334
+3,251,004
+14% +$60M
2013 Q2
7 quarters
OTEX icon
11
Open Text
OTEX
$6B
$418M 2.79%
15,847,844
+32,220
+0.2% +$921K
2013 Q2
7 quarters
CCJ icon
12
Cameco
CCJ
$30.8B
$244M 1.63%
17,535,034
+834,252
+5% +$12.5M
2013 Q2
7 quarters
GIB icon
13
CGI
GIB
$16.7B
$236M 1.57%
5,557,338
-17,270
-0.3% -$707K
2014 Q4
1 quarter
JNJ icon
14
Johnson & Johnson
JNJ
$688B
$228M 1.52%
2,267,775
-76,040
-3% -$7.73M
2013 Q2
7 quarters
POT
15
DELISTED
Potash Corp Of Saskatchewan
POT
$226M 1.51%
7,016,821
-8,484,873
-55% -$298M
2013 Q2
7 quarters
PBA icon
16
Pembina Pipeline
PBA
$29.3B
$212M 1.42%
6,711,776
+1,575,845
+31% +$50.7M
2013 Q3
6 quarters
VET icon
17
Vermilion Energy
VET
$1.66B
$211M 1.41%
5,029,021
-107,570
-2% -$4.73M
2014 Q3
2 quarters
WBA icon
18
DELISTED
Walgreens Boots Alliance
WBA
$205M 1.37%
2,415,267
+4,010
+0.2% +$319K
2013 Q2
7 quarters
PG icon
19
Procter & Gamble
PG
$394B
$198M 1.32%
2,414,286
-81,920
-3% -$7.04M
2013 Q2
7 quarters
PEP icon
20
PepsiCo
PEP
$198B
$186M 1.24%
1,941,224
-74,216
-4% -$7.18M
2013 Q2
7 quarters
CL icon
21
Colgate-Palmolive
CL
$79.2B
$185M 1.24%
2,672,281
-99,178
-4% -$6.85M
2013 Q2
7 quarters
CVS icon
22
CVS Health
CVS
$114B
$175M 1.17%
1,692,095
-111,651
-6% -$11.3M
2013 Q2
7 quarters
WFC icon
23
Wells Fargo
WFC
$258B
$172M 1.15%
3,166,307
-79,811
-2% -$4.31M
2013 Q2
7 quarters
CAE icon
24
CAE Inc
CAE
$8.92B
$162M 1.08%
13,899,748
-399,543
-3% -$4.88M
2013 Q2
7 quarters
XOM icon
25
ExxonMobil
XOM
$696B
$162M 1.08%
1,906,954
-38,160
-2% -$3.38M
2013 Q2
7 quarters

Similar funds

Jarislowsky, Fraser's Q1 2015 Portfolio in Review

As of Q1 2015, Jarislowsky, Fraser held 148 positions worth $15B, down 7.3% from $16.2B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Jarislowsky, Fraser's Q1 2015 filing shows 8 new, 33 increased, 103 reduced and 2 closed positions. Its largest new stake was Gildan: 2,415,294 shares worth $71.2M. The largest sale was Potash Corp Of Saskatchewan, an estimated $298M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 32% a quarter earlier, followed by Energy and Industrials.

  • Jarislowsky, Fraser's largest Q1 2015 buy was Gildan: 2,415,294 shares worth $71.2M.
  • Jarislowsky, Fraser added most to Enbridge in Q1 2015, an estimated $72M increase.
  • Jarislowsky, Fraser's biggest Q1 2015 reduction was Potash Corp Of Saskatchewan, cutting an estimated $298M.
  • Jarislowsky, Fraser fully exited Allergan Inc in Q1 2015, selling an estimated $110M.
  • Jarislowsky, Fraser's ten largest holdings make up 50% of its $15B portfolio in Q1 2015.
  • Jarislowsky, Fraser opened 8 new positions and closed 2 in Q1 2015.
  • Jarislowsky, Fraser's portfolio value fell 7.3% quarter-over-quarter to $15B.

Based on Jarislowsky, Fraser's 13F filing for Q1 2015, filed 13 May 2015.